Javier San Martin - Chief Medical Officer, Arrowhead Pharmaceuticals, Inc

As of November 22, 2021


What is Javier San Martin's Net Worth?

The current estimated net worth of Arrowhead Pharmaceuticals, Inc's Chief Medical Officer, Javier San Martin, is estimated to be about $71.97M . Javier San Martin owns about 111,000 units of Arrowhead Pharmaceuticals, Inc common stock. In the last year at Arrowhead Pharmaceuticals, Inc, Javier San Martin has sold an estimated value of $2.7M worth.

What is Javier San Martin's Past Insider Trading?

Javier San Martin's largest sale order was 19,500 units , worth over $1.35M on November 20, 2020. In total, Javier San Martin has made about 2 transactions over a year of their time at Arrowhead Pharmaceuticals, Inc. Javier San Martin usually trades in November, with the busiest year in 2021 and 2020. The most recent transaction was a sale order of 19,500 units , worth over $1.35M on November 22, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Javier San Martin's Salary in 2020?

As Chief Medical Officer of Arrowhead Pharmaceuticals, Inc, Javier San Martin has a total base salary of $380,769 . Javier San Martin received compensation valued at about $7,899,071 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of a bonus of $100,000 , stock awards of $7,225,500 , other earnings, plans or compensations of $180,000 , and other compensation of $12,802 .

What is Javier San Martin's' Mailing Address?

  • Mailing address is 177 E Colorado Blvd Ste 700 Pasadena CA 91105 CA

Arrowhead Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Christopher Anzalone 2020 $785,625 - $12,686,000 - $820,000 $2,892 $14,294,517
Christopher Anzalone 2019 $674,375 - - - $1,540,000 $1,889 $2,216,264
Christopher Anzalone 2018 $643,012 - - - $975,000 $1,889 $1,619,901
Kenneth Myszkowski 2020 $463,750 - $5,391,550 - $213,750 $12,802 $6,081,852
Kenneth Myszkowski 2019 $422,500 - $1,055,700 - $251,550 $11,799 $1,741,549
Kenneth Myszkowski 2018 $384,841 - $276,000 - $180,000 $12,177 $853,018
Javier San Martin 2020 $380,769 $100,000 $7,225,500 - $180,000 $12,802 $7,899,071
Javier San Martin 2019 - - - - - - -
Javier San Martin 2018 - - - - - - -
James Hassard 2020 $302,404 - $7,430,000 - $170,000 $15,892 $7,918,296
James Hassard 2019 - - - - - - -
James Hassard 2018 - - - - - - -
Curt Bradshaw 2020 $338,462 - $6,021,250 - - $13,494 $6,373,206
Curt Bradshaw 2019 - - - - - - -
Curt Bradshaw 2018 - - - - - - -
Bruce D. Given 2020 $409,615 - $15,857,500 - - $76,693 $16,343,808
Bruce D. Given 2019 $488,750 - $2,608,200 - $850,000 $11,799 $3,958,759
Bruce D. Given 2018 $450,362 - $644,000 - $445,900 $11,799 $1,552,061
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/879407/000119312521019640/d76219ddef14a.htm

What are Arrowhead Pharmaceuticals, Inc's Past Insider Trades?

Arrowhead Pharmaceuticals, Inc's most recent insider trade came on February 14, 2022 by Chris Anzalone who sold 146,388 units worth $7.6M . In the last 18 years, insiders at Arrowhead Pharmaceuticals, Inc have sold an estimated value of $157.29M and bought an estimated value of $10.21M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Chris Anzalone, Chief Executive Officer,  Kenneth Myszkowski, Chief Financial Officer,  and Charles McKenney, Director .

ARROWHEAD PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1